Furthermore, in line with the previous work, IL-2, sIL-2RA, and IL-6 levels raised during the transformation phase of CML, during progression of PMF to blast phase, and ET or PV to secondary myelofibrosis [63]. This evidence concerns the gene IL6 and chronic myelogenous leukemia, BCR-ABL1 positive.